Data protection essentials

This Overview signposts core resources on data protection essentials in the life sciences, with links to legislation, guidance and practical tools. Data protection is central to research, product development and commercialisation where special category health data are routinely processed. Practitioners must navigate the UK GDPR and the Data Protection Act 2018, together with the Privacy and Electronic Communications Regulations on communications and cookies, alongside the common law duty of confidentiality.

Key issues include identifying lawful bases and Article 9 conditions (eg research or public health) and implementing safeguards under Schedule 1 DPA 2018. Transparency, data minimisation, accuracy and storage limitation must be embedded in study design, pharmacovigilance systems, companion diagnostics and digital health offerings. Data protection impact assessments, processor due diligence, records of processing and robust security are expected. International transfers require appropriate safeguards (for example, the International Data Transfer Agreement or the Addendum to the EU Standard Contractual Clauses).

Sector - specific interfaces arise with clinical trials, real‑world evidence, biobanking and secondary use of NHS data, including approvals and confidentiality considerations overseen by the MHRA and the Health Research Authority. Practitioners should address data subject rights, exemptions...

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

Powered by Lexis+®
Latest Life Sciences News
View Life Sciences by content type :

Popular documents